These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8442108)

  • 1. Protection against autoimmune diabetes by induction of mixed bone marrow chimerism.
    Mathieu C; Vandeputte M; Bouillon R; Waer M
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1266-7. PubMed ID: 8442108
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of mixed bone marrow chimerism as potential therapy for autoimmune (type I) diabetes: experience in the NOD model.
    Mathieu C; Bouillon R; Rutgeerts O; Waer M
    Transplant Proc; 1995 Feb; 27(1):640-1. PubMed ID: 7879129
    [No Abstract]   [Full Text] [Related]  

  • 3. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice.
    Li H; Kaufman CL; Boggs SS; Johnson PC; Patrene KD; Ildstad ST
    J Immunol; 1996 Jan; 156(1):380-8. PubMed ID: 8598488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against autoimmune diabetes in mixed bone marrow chimeras: mechanisms involved.
    Mathieu C; Casteels K; Bouillon R; Waer M
    J Immunol; 1997 Feb; 158(3):1453-7. PubMed ID: 9013991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow.
    Kaufman CL; Li H; Ildstad ST
    J Immunol; 1997 Mar; 158(5):2435-42. PubMed ID: 9036994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation prevents autoimmune diabetes in nonobese diabetic mice.
    Georgiou HM; Slattery RM; Charlton B
    Transplant Proc; 1993 Oct; 25(5):2896-7. PubMed ID: 8212278
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation.
    Elkin G; Prigozhina TB; Slavin S
    Exp Hematol; 2004 Jun; 32(6):579-84. PubMed ID: 15183899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.
    Chan J; Clements W; Field J; Nasa Z; Lock P; Yap F; Toh BH; Alderuccio F
    J Gene Med; 2006 Nov; 8(11):1281-90. PubMed ID: 16989008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low levels of allogeneic but not syngeneic hematopoietic chimerism reverse autoimmune insulitis in prediabetic NOD mice.
    Kaminitz A; Mizrahi K; Yaniv I; Farkas DL; Stein J; Askenasy N
    J Autoimmun; 2009 Sep; 33(2):83-91. PubMed ID: 19632089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to the induction of mixed chimerism in spontaneously diabetic NOD mice depends on the CD40/CD154 pathway and donor MHC disparity.
    Luo B; Wu T; Pan Y; Sozen H; Hao J; Zhang Y; Sutherland DE; Hering BJ; Guo Z
    Ann N Y Acad Sci; 2007 Apr; 1103():94-102. PubMed ID: 17376827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohematopoietic reconstitution by allogeneic and autologous bone marrow grafts as a means for induction of specific unresponsiveness to donor-specific allografts and modified self in autoimmune disorders.
    Slavin S; Karussis D; Weiss L; Vourka-Karussis U; Abramsky O
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1274-5. PubMed ID: 8442110
    [No Abstract]   [Full Text] [Related]  

  • 12. [Regulatory phenomena in tolerance induction].
    Salaün J
    J Soc Biol; 2002; 196(4):259-61. PubMed ID: 12645291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
    Colson YL; Li H; Boggs SS; Patrene KD; Johnson PC; Ildstad ST
    J Immunol; 1996 Oct; 157(7):2820-9. PubMed ID: 8816385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice.
    Verda L; Kim DA; Ikehara S; Statkute L; Bronesky D; Petrenko Y; Oyama Y; He X; Link C; Vahanian NN; Burt RK
    Stem Cells; 2008 Feb; 26(2):381-6. PubMed ID: 17975228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of recipient lymphocytes in NOD mice after irradiation and bone marrow transplantation.
    Steptoe RJ; Stankovic S; Lopaticki S; Jones LK; Harrison LC; Morahan G
    J Autoimmun; 2004 Mar; 22(2):131-8. PubMed ID: 14987741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
    Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
    Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonmyeloablative bone marrow transplantation based on deletion of host-anti-donor alloreactive cells prevents autoimmune insulitis and diabetes in nonobese diabetic mice.
    Elkin G; Prighozina TB; Gurevitch O; Slavin S
    Transplant Proc; 2002 Jun; 34(4):1303-6. PubMed ID: 12072346
    [No Abstract]   [Full Text] [Related]  

  • 18. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
    Moritani M; Yoshimoto K; Wong SF; Tanaka C; Yamaoka T; Sano T; Komagata Y; Miyazaki J; Kikutani H; Itakura M
    J Clin Invest; 1998 Aug; 102(3):499-506. PubMed ID: 9691086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed bone marrow chimerism as a treatment for autoimmune diabetes.
    Leykin I; Nikolic B; Sykes M
    Transplant Proc; 2001; 33(1-2):120. PubMed ID: 11266737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.